Cmic Holdings dividend calculator – CMIC HOLDINGS Co Ltd Announces 5.0 Cash Dividend
March 18, 2023
Dividends Yield
On March 2 2023, CMIC HOLDINGS ($TSE:2309) Co Ltd announced a 5.0 cash dividend per share. This dividend follows in the footsteps of the company’s previous dividend yields of 40.0, 40.0, and 27.0 JPY per share for the last three years respectively. Over the past three years, these dividend payments have resulted in an average yield of 2.35%, making CMIC HOLDINGS a great dividend choice for those seeking passive income from their investment. For those wanting to invest in CMIC HOLDINGS’ dividend, the ex-dividend date is March 30 2023.
It is important to note that if you are considering investing in CMIC HOLDINGS, you should research the company’s financials, as dividends are not guaranteed and can change depending on the company’s profitability. Nonetheless, CMIC HOLDINGS has proven itself to be a reliable dividend payer over the past three years and is worth considering if you are looking for a dividend stock.
Market Price
The announcement resulted in a slight rise in the company’s stock price, with the stock opening at JP¥1846.0 and closing at JP¥1855.0, representing a 0.7% increase from the prior closing price of 1843.0. The stock rose on the news as investors welcomed the dividend payout and the potential for increased returns on their investments. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Cmic Holdings. More…
| Total Revenues | Net Income | Net Margin |
| 113.51k | 8.23k | 8.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cmic Holdings. More…
| Operations | Investing | Financing |
| 11.21k | -8.04k | -1.23k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cmic Holdings. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 112.19k | 69.58k | 1.86k |
Key Ratios Snapshot
Some of the financial key ratios for Cmic Holdings are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 13.9% | 42.9% | 10.7% |
| FCF Margin | ROE | ROA |
| 3.4% | 23.6% | 6.8% |
Analysis – Cmic Holdings Intrinsic Stock Value
At GoodWhale, we have conducted an in-depth analysis of CMIC HOLDINGS‘s fundamentals to determine the intrinsic value of its stock. Our proprietary Valuation Line has calculated the intrinsic value of one CMIC HOLDINGS share to be around JP¥1987.3. However, at present, CMIC HOLDINGS stock is being traded at JP¥1855.0, making it a fair price that is undervalued by 6.7%. More…
Peers
The competition between CMIC HOLDINGS Co Ltd and its competitors is fierce. IQVIA Holdings Inc, Syneos Health Inc, and Pharmigene Inc are all vying for a piece of the market share in the pharmaceutical and biotechnology industries. With each company offering unique services and products, the competition to stay ahead of the curve is intense. As the industry continues to evolve, the competition between these four companies will only become more fierce.
– IQVIA Holdings Inc ($NYSE:IQV)
IQVIA Holdings Inc is a global healthcare solutions company that provides integrated information and technology-enabled solutions to the world’s healthcare and life sciences industries. With a market cap of 40.03B as of 2023, IQVIA is one of the largest companies in the sector. Their Return on Equity (ROE) of 21.52% is impressive and shows that the company has a strong ability to generate profit from its investments. The company works to optimize and accelerate the development of new treatments and improve the health of patients around the world.
– Syneos Health Inc ($NASDAQ:SYNH)
Synos Health Inc is a leading global biopharmaceutical solutions company. It provides comprehensive clinical and commercial services to biopharmaceutical and medical device companies of all sizes, including large, midsize, and small companies. With a market cap of 3.64B as of 2023 and a Return on Equity of 8.7%, Syneos Health Inc is well-positioned to continue its impressive growth trajectory. The company’s comprehensive offerings help clients bring therapies and products to market faster and more efficiently, giving them an edge over their competition.
– Pharmigene Inc ($TPEX:7595)
Pharmigene Inc is a biotechnology company that specializes in developing treatments for rare and orphan diseases. The company has a market cap of 888.86 million dollars as of 2023 and a Return on Equity of -6.26%. The market cap is an indication of the size of the company and its value in the market, while the Return on Equity is a measure of the company’s efficiency in generating profits from its shareholders’ investments. Despite its negative ROE, Pharmigene Inc still remains a viable investment for those looking for cutting-edge treatments for rare and orphan diseases.
Summary
CMIC HOLDINGS has proved to be a reliable dividend stock over the past three years, with an average yield of 2.35%. It has consistently paid annual dividend per share of 40.0 JPY in years one and two, and 27.0 JPY in year three, resulting in dividend yields of 2.52%, 2.52%, and 2.01% respectively. For investors looking for a stable income, this stock may be worth considering.
